Rx/Reimbursement Adult Incontinence in Norway

Rx/Reimbursement Adult Incontinence in Norway

  • June 2020 •
  • 21 pages •
  • Report ID: 5376715 •
  • Format: PDF
Similar to retail adult incontinence, growth in Rx/reimbursement adult incontinence in 2019 was driven by a natural increase in demand arising from an ageing population and rising obesity rate. Norway’s reimbursement mechanism is called the “blue receipt” and applies to all diseases and medications.

Rx/Reimbursement adult incontinence in Norway report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2024 illustrate how the market is set to change.

Data coverage:
market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Rx/Reimbursement adult incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.